Latest Alzheimer's Disease News
Alzheimer’s Blood Test Predicts Who Might Benefit Most From Anti-Amyloid Drugs
Plasma phosphorylated tau 217 (p-tau217) outperformed p-tau181, p-tau231, and other blood-based biomarkers…
Alzheimer’s Drug Trials Should Report Effect Sizes, Researchers Say
Standard effect sizes are more meaningful outcomes in Alzheimer's disease drug trials…
Gantenerumab Failed to Slow Cognitive Decline in Early Alzheimer’s
Investigational gantenerumab was not associated with slower clinical decline in people with…
Subcutaneous Alzheimer’s Drug May Be on the Horizon
A subcutaneous version of the newly approved Alzheimer's drug lecanemab (Leqembi) may…
